Results 121 to 130 of about 1,216 (181)

Fraction of C. d. collilineatus venom containing crotapotin protects PC12 cells against MPP ⁺ toxicity by activating the NGF-signaling pathway. [PDF]

J Venom Anim Toxins Incl Trop Dis
Bernardes CP, Lopes Pinheiro E, Ferreira IG, de Oliveira IS, Dos Santos NAG, Sampaio SV, Arantes EC, Dos Santos AC.   +7 more
europepmc   +1 more source

Potential Biotechnological Applications of Venoms from the <i>Viperidae</i> Family in Central America for Thrombosis. [PDF]

Toxins (Basel)
Chang Estrada JE, Guerrero TN, Reyes-Enríquez DF, Nardy ES, Guimarães Ferreira R, Ruiz Calderón CJ, Wellmann IA, Monteiro Espíndola KM, do Prado AF, Soares AM, Fontes MRM, Chagas Monteiro M, Zingali RB.   +12 more
europepmc   +1 more source

Chemical modification of histidine and lysine residues of crotoxin

FEBS Letters, 1978
Jeng, Tzyy-Wen, Fraenkel-Conrat, H.
openaire   +2 more sources

Snakebite Envenomations In The Brazilian Amazon: A Little Less Neglected. [PDF]

Rev Soc Bras Med Trop
Sachett J, Wen FH, Costa AGD, Murta F, Carvalho ES, Araújo FQ, Machado VA, Silva Neto AVD, Bisneto PF, Val F, Ferreira LCL, Figueira E, Sartim MA, Monteiro W.   +13 more
europepmc   +1 more source

Crotalus durissus terrificus snake venom activates 3T3-L1 preadipocytes to release PGE₂, which depends on COX-2 expression and is modulated by PGE₂ EP2 receptor. [PDF]

Arch Toxicol
Teixeira DS, Maia-Marques R, Teixeira C.
europepmc   +1 more source

Effect of animal venom toxins on the main links of the homeostasis of mammals (Review). [PDF]

Biomed Rep
Matkivska R, Samborska I, Maievskyi O.
europepmc   +1 more source

Isolation and Pharmacological Characterisation of Pre-Synaptic Neurotoxins from Thai and Javanese Russell's Viper (Daboia siamensis) Venoms. [PDF]

Toxins (Basel)
Lay M, Hodgson WC.
europepmc   +1 more source

[The crotoxin case].

Medicina, 1987
openaire   +1 more source

Comparative Analysis of the Enzymatic, Coagulant, and Neuromuscular Activities of Two Variants of Crotalus durissus ruruima Venom and Antivenom Efficacy. [PDF]

Pharmaceuticals (Basel)
Demico PJ, Oliveira IN, Proença-Hirata VS, Dias SR, Ghirotti HA, Silva EO, Giometti IC, Pacagnelli FL, Torres-Bonilla KA, Hyslop S, Galizio NC, de Morais-Zani K, Pucca MB, Rocha AM, Maciel JB, Sartim MA, Monteiro WM, Floriano RS.   +17 more
europepmc   +1 more source

Potential of Venom-Derived Compounds for the Development of New Antimicrobial Agents. [PDF]

Toxins (Basel)
Rabea EY, Mahmoud ED, Mohamed NK, Ansary ER, Alrouby MR, Shehata RR, Mokhtar YY, Arullampalam P, Hegazy AM, Al-Sabi A, Abd El-Aziz TM.   +10 more
europepmc   +1 more source